New Trial Data Continue to Support DPX-Survivac in Treating Advanced Ovarian Cancer
News
Immune responses in women with advanced ovarian cancer being treated with DPX-Survivac in clinical trials continue to support the immunotherapy’s potential, alone or in combination, to be effective in this patient population. DPX-Survivac, ... Read more